Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article

François Fasquelle,Angelo Scuotto,Michael Howsam,Didier Betbeder

DOI: https://doi.org/10.3390/pharmaceutics16020247

IF: 6.525

2024-02-08

Pharmaceutics

Abstract:Nanoparticles are increasingly being studied as antigen delivery systems for immunization with nasal vaccines. The addition of adjuvants is still generally required in many nanoparticle formulations, which can induce potential side effects owing to mucosal reactogenicity. In contrast, maltodextrin nanoparticles do not require additional immunomodulators, and have been shown to be efficient vaccine delivery systems. In this review, the development of maltodextrin nanoparticles is presented, specifically their physico-chemical properties, their ability to load antigens and deliver them into airway mucosal cells, and the extent to which they trigger protective immune responses against bacterial, viral, and parasitic infections. We demonstrate that the addition of lipids to maltodextrin nanoparticles increases their potency as a vaccine delivery system for nasal administration.

pharmacology & pharmacy

What problem does this paper attempt to address?

This paper aims to explore the development and application of maltodextrin nanoparticles (MDNPs) as a nasal vaccine delivery system. Specifically, the paper focuses on the following aspects:

1. **Physicochemical properties of MDNPs**: The paper describes in detail the synthesis method of MDNPs and their physicochemical characteristics, such as surface charge, particle size, etc. These characteristics are crucial for their use as vaccine carriers.

2. **Antigen - loading capacity**: MDNPs can efficiently load antigens. Through the "post - loading" technique, antigens such as proteins are encapsulated inside the nanoparticles by electrostatic interaction. Research shows that MDNPs can load proteins up to 200% of their own weight, and the encapsulation efficiency reaches 100%.

3. **Cellular interactions**: The paper discusses how MDNPs interact with cells, especially how they are endocytosed by cells and the subsequent intracellular transport processes. It has been found that MDNPs can enter cells through the clathrin - mediated endocytosis pathway and are finally excreted from cells through the cholesterol - mediated exocytosis pathway. This process helps to reduce intracellular accumulation and potential toxicity.

4. **Immune response**: MDNPs can effectively trigger a protective immune response against bacterial, viral and parasitic infections. The paper also mentions that adding lipids can further improve the vaccine delivery effect of MDNPs.

5. **Safety and efficacy**: The paper emphasizes the safety and efficacy of MDNPs as a nasal vaccine delivery system. In particular, without using additional immunomodulators, MDNPs can still induce a strong immune response while avoiding the side effects commonly seen in traditional vaccines.

In summary, the problem that this paper attempts to solve is how to use maltodextrin nanoparticles as a nasal vaccine delivery system to improve the safety and efficacy of vaccines while reducing side effects.